SNS Financial Group’s Actinium Pharmaceuticals ATNM Stock Holding History

SNS Financial Group’s Portfolio ATNM Stock Details ATNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,167	Closed	-$8K	–	198
2019 Q4	$8K	Hold	1,167	–	–	﹤0.01%	223
2019 Q3	$8K	Hold	1,167	–	–	﹤0.01%	203
2019 Q2	$9K	Buy	1,167 +300	+35%	+$3.01K	﹤0.01%	211
2019 Q1	$12K	Hold	867	–	–	﹤0.01%	190
2018 Q4	$10K	Hold	867	–	–	﹤0.01%	193
2018 Q3	$19K	Hold	867	–	–	﹤0.01%	178
2018 Q2	$17K	Hold	867	–	–	﹤0.01%	172
2018 Q1	$9K	Buy	867 +200	+30%	+$3.4K	﹤0.01%	166
2017 Q4	$13K	Buy	667 +67	+11%	+$1.35K	﹤0.01%	174
2017 Q3	$10K	Buy	600 +200	+50%	+$4.39K	﹤0.01%	168
2017 Q2	$15K	Buy	400 +67	+20%	+$2.8K	﹤0.01%	163
2017 Q1	$15K	Buy	+333	New	+$12.8K	﹤0.01%	200

Other funds holding ATNM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

SNS Financial Group's ATNM Position: Q1 2020 in Review

SNS Financial Group sold out of Actinium Pharmaceuticals (ATNM) in Q1 2020, closing a stake of 1,167 shares — an estimated $8K sold.

SNS Financial Group first reported a position in ATNM in Q1 2017 and held it in 12 quarters. The position peaked at $19K in Q3 2018. 42 funds tracked by Wall St. Rank hold ATNM as of Q1 2020.

SNS Financial Group reported no remaining Actinium Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
SNS Financial Group sold 1,167 Actinium Pharmaceuticals shares in Q1 2020, an estimated $8K.
SNS Financial Group first reported a position in Actinium Pharmaceuticals in Q1 2017 and held it in 12 quarters.
SNS Financial Group's Actinium Pharmaceuticals position peaked at $19K in Q3 2018.
42 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q1 2020.

Based on SNS Financial Group's 13F filing for Q1 2020, filed 7 May 2020.